ArticleNature communications2020
An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses.
Guan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
150 papers cite itlatest 60 shown
this papercites it